Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus ›
Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus ›
Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia ›
June 25th, 2019 – June 29th, 2019
The views expressed in this video are those of Joseph R. Madsen, MD and do not necessarily reflect the views of Anuncia, our partners, collaborators, representatives, or subsidiaries.